
Premal Thaker, MD, MS, discusses important implications and takeaways of the phase 1/2 OVATION study of IMMN-1 in addition to chemotherapy for the treatment of newly diagnosed epithelial ovarian cancer.

Your AI-Trained Oncology Knowledge Connection!

Premal Thaker, MD, MS, is a gynecologic oncologist at Siteman Cancer Center, Washington University in St. Louis.